Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China

Journal of Clinical Virology

Volumn 53, Issue 1, 2012, Pages 33-37

  Xu, Sihong ^a   Song, Aijing ^a   Nie, Jianhui ^a   Li, Xiuhua ^a   Meng, Shufang ^a   Zhang, Chuntao ^a   Wang, Youchun ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

CAP CTM v1.0; CAP CTM v2.0; EasyQ v2.0; HIV 1 genotypes; Performance

Indexed keywords

ACCURACY; ARTICLE; CHINA; CLADISTICS; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS LOAD;

CHINA; CLINICAL LABORATORY TECHNIQUES; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 83355166801     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.10.001     Document Type: Article

References (25)

1. MacDougall D.S. Quantitative measurement of HIV RNA: techniques & clinical applications. J Int Assoc Physicians AIDS Care 1996, 2(11):9-14.
2. Peter J.B., Blum R.A. Monitoring HIV viral loads in the United States: recent trends and methodologies. J Acquir Immune Defic Syndr 2002, 30(2):261-262.
3. Saag M.S., Holodniy M., Kuritzkes D.R., O'Brien W.A., Coombs R., Poscher M.E., et al. HIV viral load markers in clinical practice. Nat Med 1996, 2(6):625-629.
4. ® HIV RNA quantitative assays. J Virol Methods 2006, 137(2):184-192.
5. Braun P., Ehret R., Wiesmann F., Zabbai F., Knickmann M., Kühn R., et al. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin Chem Lab Med 2007, 45(1):93-99.
6. Gottesman B.S., Grossman Z., Lorber M., Levi I., Shitrit P., Katzir M., et al. Comparative performance of the Amplicor HIV-1 Monitor assay versus NucliSens EasyQ in HIV subtype C-infected patients. J Med Virol 2006, 78(7):883-887.
7. Gill M.J., Beckthold B., Church D., Kim J. The impact of genetic diversity on viral load quantification [abstract no. TUPEB059]. 4th IAS Conference on HIV Pathogesis, Treatment and Prevention 2007.
8. Gueudin M., Plantier J.C., Lemée V., Schmitt M.P., Chartier L., Bourlet T., et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction- quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007, 44(5):500-505.
9. van Deursen P., Oosterlaken T., Andre P., Verhoeven A., Bertens L., Trabaud M.A., et al. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSens EasyQ HIV-1 v2.0. J Clin Virol 2010, 47(2):120-125.
10. Sizmann D., Glaubitz J., Simon C.O., Goedel S., Buergisser P., Drogan D., et al. Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach. J Clin Virol 2010, 49(1):41-46.
11. Bourlet T., Signori-Schmuck A., Roche L., Icard V., Saoudin H., Trabaud M.A., et al. HIV-1 Load Comparison Using Four Commercial Real-Time Assays. J Clin Microbiol 2011, 49(1):292-297.
12. Lesley Scott, Sergio Carmona, Wendy Stevens Performance of the New Roche Cobas AmpliPrep-Cobas TaqMan Version 2.0 Human Immunodeficiency Virus Type 1 Assay. J Clin Microbiol 2009, 47(10):3400-3402.
13. Damond F., Avettand-Fenoel V., Collin G., Roquebert B., Plantier J.C., Ganon A., et al. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J Clin Microbiol 2010, 48(4):1413-1416.
14. Han X.X., Zhang M., Cui W.G., Liu B.G., Wang Y., Zhang Z.N., et al. Efficacy of anti-HIV treatment and drug-resistance mutations in some parts of China. Zhonghua Yi Xue Za Zhi 2005, 85(11):760-764. [in Chinese].
15. Li J.Y., Li H.P., Li L., Li H., Wang Z., Yang K., et al. Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res 2005, 15(11):843-849.
16. Yang K., Li J.Y., Bao Z.Y., Li L., Zhuang D.M., Wang Z., et al. Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naive AIDS patients in Henan province. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26(5):351-355. [in Chinese].
17. Zhong P., Pan Q., Ning Z., Xue Y., Gong J., Zhen X., et al. Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses 2007, 23(7):847-856.
18. Liao L., Xing H., Shang H., Li J., Zhong P., Kang L., et al. The prevalence of drug resistance in treatment naïve HIV-infected individuals in China. J Acquir Immune Defic Syndr 2010, 53(S1):S10-S14.
19. Yang R., Kusagawa S., Zhang C., Xia X., Ben K., Takebe Y. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol 2003, 77(1):685-695.
20. Zhang L., Chen Z., Cao Y., Yu J., Li G., Yu W., et al. Molecular characterization of human immunodeficiency virus type 1 and Hepatitis C virus in paid blood donors and injection drug users in china. J Virol 2004, 78(24):13591-13599.
21. Zhang Y., Lu L., Ba L., Liu L., Yang L., Jia M., et al. Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med 2006, 3(11):e443.
22. Lu L., Jia M., Ma Y., Yang L., Chen Z., Ho D.D., et al. The changing face of HIV in China. Nature 2008, 455(7213):609-611.
23. Wang Y., Song A., Xu S., Li X., Chong H., Zhao C., et al. Impact of HIV-1 genetic diversity in China on the measurement of viral load. J Med Virol 2008, 80(1):1-8.
24. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1(8476):307-310.
25. Xu S., Song A., Nie J., Li X., Li J., Bao Z., et al. Comparative evaluation of the COBAS AmpliPrep/COBAS TaqMan HIV type 1 test (CAP/CTM) and VERSANT HIV type 1 RNA 3.0 assay (bDNA) for quantifying HIV type 1 viral loads in China. AIDS Res Hum Retroviruses 2008, 24(11):1365-1373.